CUFinder

Sangita Pal

Sangita Pal

Harvard University

H-index: 12

North America-United States

Contact Sangita Pal

About Sangita Pal

Sangita Pal, With an exceptional h-index of 12 and a recent h-index of 10 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Biomedical Science.

His recent articles reflect a diverse array of research interests and contributions to the field:

EXTH-95. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system

HGG-32. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Author correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Mechanisms and therapeutic implications of hypermutation in gliomas

Sangita Pal Information

University

Position

Dana-Farber Cancer Institute, Harvard Medical School

Citations(all)

2021

Citations(since 2020)

1572

Cited By

967

hIndex(all)

12

hIndex(since 2020)

10

i10Index(all)

13

i10Index(since 2020)

12

Email

University Profile Page

Google Scholar

Sangita Pal Skills & Research Interests

Biomedical Science

Top articles of Sangita Pal

EXTH-95. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS

Neuro-Oncology

2022/11/1

Sangita Pal
Sangita Pal

H-Index: 10

Mehdi Touat
Mehdi Touat

H-Index: 19

David Root
David Root

H-Index: 12

Rameen Beroukhim
Rameen Beroukhim

H-Index: 115

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system

JCI insight

2022/10/10

Bernhard Englinger
Bernhard Englinger

H-Index: 9

Smitha Yerrum
Smitha Yerrum

H-Index: 7

Sangita Pal
Sangita Pal

H-Index: 10

Eshini Panditharatna
Eshini Panditharatna

H-Index: 7

Daeun Jeong
Daeun Jeong

H-Index: 3

Rameen Beroukhim
Rameen Beroukhim

H-Index: 115

HGG-32. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS

Neuro-Oncology

2020/12

Sangita Pal
Sangita Pal

H-Index: 10

Mehdi Touat
Mehdi Touat

H-Index: 19

Rameen Beroukhim
Rameen Beroukhim

H-Index: 115

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Nature genetics

2020/7/2

Veronica Rendo
Veronica Rendo

H-Index: 4

Sangita Pal
Sangita Pal

H-Index: 10

Julian Hess
Julian Hess

H-Index: 20

Anwesha Nag
Anwesha Nag

H-Index: 16

Francisca Vazquez
Francisca Vazquez

H-Index: 38

Rameen Beroukhim
Rameen Beroukhim

H-Index: 115

Uri Ben-David
Uri Ben-David

H-Index: 23

Author correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Nature Genetics

2020/7

Veronica Rendo
Veronica Rendo

H-Index: 4

Sangita Pal
Sangita Pal

H-Index: 10

Julian Hess
Julian Hess

H-Index: 20

Anwesha Nag
Anwesha Nag

H-Index: 16

Francisca Vazquez
Francisca Vazquez

H-Index: 38

Rameen Beroukhim
Rameen Beroukhim

H-Index: 115

Uri Ben-David
Uri Ben-David

H-Index: 23

Mechanisms and therapeutic implications of hypermutation in gliomas

Nature

2020/4/23

Mehdi Touat
Mehdi Touat

H-Index: 19

Sangita Pal
Sangita Pal

H-Index: 10

Frank Dubois
Frank Dubois

H-Index: 5

Aniket Shetty
Aniket Shetty

H-Index: 7

Radwa Sharaf
Radwa Sharaf

H-Index: 10

Philippe Cornu
Philippe Cornu

H-Index: 4

Wenya Linda Bi
Wenya Linda Bi

H-Index: 35

Sandro Santagata
Sandro Santagata

H-Index: 53

Peter J Park
Peter J Park

H-Index: 84

Rameen Beroukhim
Rameen Beroukhim

H-Index: 115

See List of Professors in Sangita Pal University(Harvard University)